Di Leo E, Delle Donne P, Calogiuri G F, Macchia L, Nettis E
Unit of Internal Medicine, Section of Allergy and Clinical Immunology, "F. Miulli" Hospital, Acquaviva delle Fonti, BA Italy.
2Department of Emergency and Organ Transplantation, School and Chair of Allergology and Clinical Immunology, University of Bari-Aldo Moro, Bari, Italy.
Clin Mol Allergy. 2018 Jul 9;16:16. doi: 10.1186/s12948-018-0094-7. eCollection 2018.
Adverse reactions (ARs) to drugs administered during general anesthesia may be very severe and life-threatening, with a mortality rate ranging from 3 to 9%. The adverse reactions to drugs may be IgE and non-IgE-mediated. Neuromuscular blocking agents (NMBA) represent the first cause of perioperative reactions during general anesthesia followed by latex, antibiotics, hypnotic agents, opioids, colloids, dyes and antiseptics (chlorhexidine). All these substances (i.e. NMBA, anesthetics, antibiotics, latex devices) may cause severe systemic non-IgE-mediated reactions or fatal anaphylactic events even in the absence of any evident risk factor in the patient's anamnesis. For this reason, in order to minimize perioperative anaphylactic reactions, it is important to have rapid, specific, sensitive in vitro diagnostic tests able to confirm the clinical diagnosis of acute anaphylaxis.
全身麻醉期间使用药物的不良反应(ARs)可能非常严重且危及生命,死亡率在3%至9%之间。药物不良反应可能由IgE介导和非IgE介导。神经肌肉阻滞剂(NMBA)是全身麻醉期间围手术期反应的首要原因,其次是乳胶、抗生素、催眠剂、阿片类药物、胶体、染料和防腐剂(洗必泰)。即使患者既往史中没有任何明显的危险因素,所有这些物质(即NMBA、麻醉剂、抗生素、乳胶器械)也可能导致严重的全身性非IgE介导反应或致命的过敏反应。因此,为了将围手术期过敏反应降至最低,拥有能够快速、特异性、灵敏地确认急性过敏反应临床诊断的体外诊断测试非常重要。